| Literature DB >> 29186761 |
Oana Lelia Pop1, Francisc Vasile Dulf2, Lucian Cuibus1, Marta Castro-Giráldez3, Pedro J Fito3, Dan Cristian Vodnar1, Cristina Coman1, Carmen Socaciu1, Ramona Suharoschi1.
Abstract
Probiotics are bacteria that can provide health benefits to consumers and are suitable to be added to a variety of foods. In this research, viability of immobilized Lactobacillus casei in alginate with or without sea buckthorn lipid extract were studied during heat treatment and with an in vitro gastrointestinal model. The characterization of the lipid extract was also done using the UV-Vis spectrometry (UV-Vis), high-performance liquid chromatography photodiode array detection method (HPLC-PDA), gas chromatography coupled with mass spectrometry (GS-MS) and Cryo scanning electron microscopy (Cryo-SEM). During heat treatment, the entrapped probiotic cells proved high viability (>6 CFU log/g), even at temperatures above 50 °C. The rich in monounsaturated fatty acids sea buckthorn fraction improved the in vitro digestion passage regarding the probiotic viability. The survival of the probiotic cells was 15% higher after 2 h in the acidic medium of the simulated gastric fluid in the sample where L. casei was encapsulated with the sea buckthorn extract compared with the samples where no extract was added. Thus, this approach may be effective for the future development of probiotic-supplemented foods as foods with health welfare for the consumers.Entities:
Keywords: Lactobacillus casei; encapsulation; gastrointestinal passage; heat treatment; sea buckthorn
Mesh:
Substances:
Year: 2017 PMID: 29186761 PMCID: PMC5751116 DOI: 10.3390/ijms18122513
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Fatty acid compositions (molar % of total fatty acids) (determined by GS-MS) of total lipids from the lipid fraction of sea buckthorn (free and encapsulated).
| Fatty Acids | SE Lipid Fraction | SE from Capsules | ||
|---|---|---|---|---|
| % | SD | % | SD | |
| Caprylic | 0.04 | 0.01 | 0.01 | 0.01 |
| Capric | 0.03 | 0.01 | 0.02 | 0.01 |
| Lauric | 0.04 | 0.01 | 0.05 | 0.01 |
| Myristic | 0.18 | 0.02 | 0.20 | 0.02 |
| Z-11-Tetradecenoic acid | 0.05 | 0.01 | 0.02 | 0.01 |
| Pentadecanoic | 0.07 | 0.02 | 0.06 | 0.01 |
| Palmitic | 26.59 | 1.33 | 27.94 | 1.45 |
| 7-Hexadecenoic acid | 0.03 | 0.01 | 0.03 | 0.01 |
| Palmitoleic | 26.2 | 1.31 | 25.15 | 1.30 |
| Margaric acid | 0.02 | 0.01 | 0.04 | 0.01 |
| Stearic | 1.11 | 0.06 | 1.13 | 0.06 |
| Oleic | 27.73 | 1.40 | 27.83 | 1.35 |
| Vaccenic | 10.73 | 0.55 | 10.05 | 0.45 |
| Linoleic | 5.42 | 0.25 | 5.73 | 0.29 |
| Alfa-linolenic | 1.45 | 0.07 | 1.36 | 0.07 |
| Arachidic | 0.14 | 0.02 | 0.14 | 0.01 |
| Gondoic | 0.11 | 0.02 | 0.16 | 0.02 |
| Behenic | 0.02 | 0.01 | 0.03 | 0.01 |
| Erucic | 0.03 | 0.01 | 0.08 | 0.01 |
The values represent the mean of tree samples, analyzed in triplicate. SD, standard deviation.
The composition (molar % of total fatty acids) classed in total lipids from the lipid fraction of sea buckthorn (free and encapsulated).
| Fatty Acids | SE lipid Fraction | SE from Capsules |
|---|---|---|
| ΣSFAs | 28.25 ± 1.41 ba | 29.62 ± 1.48 ba |
| ΣMUFAs | 64.88 ± 3.24 aa | 63.29 ± 3.16 aa |
| ΣPUFAs | 6.87 ± 0.34 ca | 7.09 ± 0.35 ca |
| n-3 PUFA | 1.45 ± 0.07 a | 1.36 ± 0.07 a |
| n-6 PUFA | 5.42 ± 0.27 a | 5.73 ± 0.29 a |
| n-6/n-3 | 3.74 a | 4.21 a |
| PUFAs/SFAs | 0.24 a | 0.24 a |
Values represent mean ± SD of three samples analyzed individually in triplicate (n = 3 × 3). The means in the same column followed by different superscript letters (a, b, c) indicate significant differences (p < 0.05) among fatty acid classes (ANOVA “Tukey’s Multiple Comparison Test”). The means in the same row followed by different subscript letters indicate no significant differences (p < 0.05) among lipid classes of samples (unpaired t-test); SFAs, saturated fatty acids; MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids.
Figure 1Micrographies of fresh sea buckthorn: (a) epidermic tissue at 1000×; (b) epidermic tissue at 1500×; (c) parenchymatic tissue at 750×; (d) parenchymatic tissue at 1500×; (e) fat globules detail at 5000×; and (f) fat globules detail at 10,000×. E, Epidermic tissue; EC, Epidermic cells; ES, Extracellular space; FG, Fat globules; and CW, Cell wall.
Size and encapsulation yield.
| Microparticles | Microparticles Size (µm) ( | Encapsulation Yield (%) ( |
|---|---|---|
| Alginate 1.5% | 1255.5 ± 12.7 | 96.13 ± 0.28 a |
| Alginate 1.5% and 10% SE | 1285.5 ± 1.3 | 98.46 ± 1.08 b |
The means ± SD with different letters (a, b) in the same column are significantly different (n = 3, p < 0.05). SE, sea buckthorn lipid fraction; n, number of measured capsules.
Temperature variation in 250 mL yogurt in correlation with the time and the microwave frequency. Temperature unit is °C. Viability of probiotic cells YLE, yogurt with encapsulated L. casei; YLS, yogurt with added L. casei and 10% sea buckthorn lipid fraction; and YLSE, yogurt with encapsulated L. casei and 10% sea buckthorn lipid fraction after microwave treatment at: 100; 450; and 850 W. Values represent mean ± SD of three samples, analyzed individually in triplicate (n = 3 × 3).
| Treatment Time (s) | 0 | 10 | 30 | 60 | 90 | 120 | ||
|---|---|---|---|---|---|---|---|---|
| Microwave Power/Sample | ||||||||
| 100 W | YLS | CFU log/g | 7.58 ± 0.07 | 6.69 ± 0.21 | 7.28 ± 0.14 | 7.26 ± 0.05 | 7.75 ± 0.32 | 8.33 ± 0.41 |
| YLE | 7.89 ± 0.5 | 8.36 ± 0.12 | 7.32 ± 0.22 | 7.31 ± 0.5 | 7.45 ± 0.02 | 8.03 ± 0.14 | ||
| YLES | 8.17 ± 0.21 | 8.53 ± 0.4 | 8.42 ± 0.13 | 8.63 ± 0.18 | 8.31 ± 0.5 | 9.05 ± 0.22 | ||
| Temp °C | 4 ± 0.2 | 5.5 ± 0.2 | 7.14 ± 0.2 | 13.2 ± 0.2 | 19.5 ± 0.2 | 23.2 ± 0.2 | ||
| 450 W | YLS | CFU log/g | 7.47 ± 0.12 | 7.74 ± 0.23 | 7.44 ± 0.2 | 8.12 ± 0.4 | 8.66 ± 0.24 | 8.87 ± 0.09 |
| YLE | 7.89 ± 0.51 | 7.65 ± 0.2 | 7.39 ± 0.12 | 7.36 ± 0.15 | 8.11 ± 0.8 | 8.98 ± 0.18 | ||
| YLES | 7.78 ± 0.29 | 7.80 ± 0.02 | 7.62 ± 0.05 | 7.56 ± 0.5 | 7.79 ± 0.17 | 9.21 ± 0.13 | ||
| Temp °C | 4 ± 0.2 | 6.3 ± 0.2 | 12 ± 0.2 | 18.7 ± 0.2 | 39 ± 0.2 | 41 ± 0.2 | ||
| 850 W | YLS | CFU log/g | 7.65 ± 0.03 | 7.65 ± 0.45 | 7.52 ± 0.32 | 7.77 ± 0.15 | 6.16 ± 0.16 | 3.81 ± 0.4 |
| YLE | 7.89 ± 0.22 | 7.84 ± 0.41 | 7.68 ± 0.35 | 8.38 ± 0.05 | 6.83 ± 0.09 | 4.12 ± 0.12 | ||
| YLES | 8.06 ± 0.19 | 7.89 ± 0.16 | 7.84 ± 0.24 | 8.86 ± 0.41 | 7.69 ± 0.32 | 5.56 ± 0.24 | ||
| Temp °C | 4 ± 0.2 | 11.4 ± 0.2 | 14.9 ± 0.2 | 30 ± 0.2 | 55 ± 0.2 | 64.5 ± 0.2 | ||
Figure 2The viability of L. casei encapsulated with or without sea buckthorn lipid fraction, after the in vitro static digestion assay. SSF, simulated saliva fluid; SGF, simulated gastric fluid; SIF, simulated intestinal fluid; #, the sample treated 0.5 h in SGF; *, the sample treated 2 h in SGF; a, b, different letters in the same group mean significant difference (p < 0.05, n = 3 × 3).
Experimental design for evaluation of sea buckthorn extract addition effect on probiotic cell viability in different microwave treatment of inoculated yogurt.
| Yogurt trials | SE* | Sample Coding |
|---|---|---|
| Yogurt with | 10% | YLS |
| Yogurt with | - | YLE |
| Yogurt with | 10% | YLSE |
SE*—sea buckthorn lipid fraction.